-
VX-702 CHEMBL1090090
Alternate Names:
VX-702 6-[(AMINOCARBONYL)(2,6-DIFLUOROPHEN YL)AMINO]-2-(2,4-DIFLUOROPHENYL)-3-PYRIDINECARBOXAMIDE 6-(N-CARBAMOYL-2,6-DIFLUOROANILINO)-2-(2,4-DIFLUOROPHENYL)PYRIDINE-3-CARBOXAMIDE 6-(N-CARBAMOYL-2,6-DIFLUORO-ANILINO)-2-(2,4-DIFLUOROPHENYL)PYRIDINE-3-CARBOXAMIDE 479543-46-9 , C19H12F4N4O2 , VX702 , VX 702 BRD-K07736136-001-01-2 W-5489 S-7778 A19416 EC-000.2363 Y0260 FT-0696780 FT-0675854 FT-0652364 RT-016249 KB-198954 SMR004702934 KB-81473 HY-10401 HE067027 BC665780 4CA-1339 NCGC00249684-01 6-[CARBAMOYL-(2,6-DIFLUOROPHENYL)AMINO]-2-(2,4-DIFLUOROPHENYL)PYRIDINE-3-CARBOXAMIDE VX-702-SUPPLIED BY SELLECK CHEMICALS CS-0074 AN-5334 AKOS015902395 ZINC36377992 VX-702/VX702 RS0060 DCL000260 BDBM50314071 ABP000258 HMS3244H12 HMS3244H08 HMS3244H04 BCPP000016 MOLPORT-021-805-020 FYSRKRZDBHOFAY-UHFFFAOYSA-N CHEBI:719385 SYN1093 QCR-232 AOB6303 CTK8E9206 GTPL6059 SCHEMBL185712 MLS006011165 PUBCHEM22492 CID10341154 6-[(AMINOCARBONYL)(2,6-DIFLUOROPHENYL)AMINO]-2-(2,4-DIFLUOROPHENYL)-3-PYRIDINECARBOXAMIDE VX702, VX-702 C19H12F4N4O2 2-(2,4-DIFLUOROPHENYL)-6-[1-(2,6-DIFLUOROPHENYL)CARBAMOYLAMINO]PYRIDINE-3-CARBOXAMIDE ST51054128 1-(5-CARBAMOYL-6-(2,4-DIFLUOROPHENYL)PYRIDIN-2-YL)-1-(2,6-DIFLUOROPHENYL)UREA I14-1965 KINOME_3176 S6005_SELLECK 2-(2,4-DIFLUOROPHENYL)-6-(1-(2,6-DIFLUOROPHENYL)UREIDO)NICOTINAMIDE 745833-23-2 VX702 VX 702 479543-46-9 10341154 AB0035846 DB05470 178102680 6059 85154293 Drug Info:
FDA Approval not approved Drug Class small molecule Drug Indications antiinflammatory agent,cardiovascular agent Drug Categories urea Drug Categories organic chemicals Drug Categories hydrocarbons, cyclic Drug Categories hydrocarbons, aromatic Drug Categories hydrocarbons Drug Categories benzene derivatives Drug Groups investigational Drug Type small molecule Publications:
-
Interaction Types:
inhibitor Interaction Info:
Mechanism of Interaction MAP kinase p38 alpha inhibitor Direct Interaction yes Specific Action of the Ligand Inhibition Publications:
-
Interaction Types:
inhibitor Interaction Info:
Specific Action of the Ligand Inhibition Endogenous Drug? False Direct Interaction? True Publications:
-
Interaction Types:
inhibitor Interaction Info:
Trial Name VX-702 Novel drug target Novel Target Publications:
-
Interaction Types:
n/a Interaction Info:
Trial Name VX-702 Novel drug target Novel Target Publications:
-
Interaction Types:
n/a Interaction Info:
Publications:
-
Interaction Types:
n/a Interaction Info:
Publications:
-
Interaction Types:
n/a Interaction Info:
Publications:
-
Alternate Names:
VX-702 DrugBank Drug Name Drug Info:
Drug Type small molecule Drug Groups investigational Drug Categories benzene derivatives Publications:
-
- Version: January-2014
Alternate Names:
Drug Info:
Drug Indications antiinflammatory agent,cardiovascular agent Drug Class small molecule FDA Approval not approved Publications:
-
Alternate Names:
AB0035846 Drug Synonym VX-702 pubchem_primary_name 10341154 PubChem CID Drug Info:
Publications:
-
Alternate Names:
ST51054128 Drug Synonym CHEMBL1090090 Drug Synonym 6-[CARBAMOYL-(2,6-DIFLUOROPHENYL)AMINO]-2-(2,4-DIFLUOROPHENYL)PYRIDINE-3-CARBOXAMIDE Drug Synonym Drug Info:
Publications:
-
- Version: 27-September-2017
Alternate Names:
VX-702 GuideToPharmacology Ligand Name 178102680 PubChem Drug SID Drug Info:
Publications:
-
- Version: chembl_23
Alternate Names:
Drug Info:
Publications: